← Eichor
Condition: Hiv Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901
Structured Peer-delivered ART and Reentry Community Strategy
NA · 1 location(s) · Johns Hopkins University · NCT06027671
The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation
NA · 6 location(s) · Northwestern University · NCT06880224
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Phase 4 · 3 location(s) · University of Witwatersrand, South Africa · NCT06485154
Improving Engagement in HIV and Cancer Care in Zimbabwe
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06934369
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07388394
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097
Accelerated ART Initiation for PWHIV Who Are Out of Care
Phase 4 · 4 location(s) · University of Missouri-Columbia · NCT06374758
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
NA · 1 location(s) · University of California, San Francisco · NCT07125235
Strategies to AchieVe Viral Suppression for Youth With HIV
NA · 1 location(s) · Johns Hopkins University · NCT06886971
Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
NA · 1 location(s) · University of Washington · NCT06745050
DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Phase 2 · 4 location(s) · University Hospital, Caen · NCT06034938
Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546
Gathering Records to Evaluate Antiretroviral Treatment-South Africa
Phase N/A · 1 location(s) · Boston University · NCT04149782
Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa
NA · 1 location(s) · Emory University · NCT07226323
Low Dose Naltrexone for Pain in Patients With HIV
Phase 4 · 3 location(s) · Emory University · NCT05537935
Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
NA · 1 location(s) · University of Colorado, Denver · NCT06117163
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06558825
Menopausal HT for Women Living With HIV (HoT)
Phase 4 · 23 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT06856174
Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )
Phase N/A · 1 location(s) · Boston University · NCT04158882
A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527
Universal Basic Income and Structural Racism in the US South: HIV Care
NA · 1 location(s) · University of Arkansas · NCT06186128
Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
NA · 1 location(s) · University of North Carolina, Chapel Hill · NCT06096324
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmi
NA · 3 location(s) · University of North Carolina, Chapel Hill · NCT06493357
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Phase 2 · 10 location(s) · Naga P. Chalasani · NCT07143968
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.